Thromboembolic disease in pregnancy

被引:12
作者
Doyle, NM
Monga, M
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Obstet Gynecol & Reprod Sci, Div Maternal Fetal Med, Houston, TX 77030 USA
[2] Univ Texas, Grad Sch Biomed Sci, Houston, TX 77030 USA
关键词
D O I
10.1016/j.ogc.2004.03.008
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Venous thromboembolic disease is a major cause of maternal morbidity and mortality. Virchow's triad of hypercoagulability, venous stasis, and vascular damage all occur during pregnancy. The risk of venous thromboembolism is five to six times higher during pregnancy and the puerperium. Risk factors include age greater than 35, antiphospholipid antibodies, inherited thrombophilias, operative delivery, increased parity, obesity, mechanical heart valves, and family history. Prophylactic and therapeutic anticoagulation is recommended for women at risk. Low molecular weight heparins are safe and effective in most cases.
引用
收藏
页码:319 / +
页数:27
相关论文
共 79 条
[61]   RANDOMIZED TRIAL OF EPIDURAL VERSUS INTRAVENOUS ANALGESIA DURING LABOR [J].
RAMIN, SM ;
GAMBLING, DR ;
LUCAS, MJ ;
SHARMA, SK ;
SIDAWI, JE ;
LEVENO, KJ .
OBSTETRICS AND GYNECOLOGY, 1995, 86 (05) :783-789
[62]   Prophylaxis and treatment of thromboembolic diseases during pregnancy with dalteparin [J].
Rey, E ;
Rivard, GE .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2000, 71 (01) :19-24
[63]  
REY E, 1999, 17 C INT SOC THROMB
[64]  
ROSENBERG RD, 1975, NEW ENGL J MED, V292, P146
[65]   HIGH-RISK OF THROMBOSIS IN PATIENTS HOMOZYGOUS FOR FACTOR-V LEIDEN (ACTIVATED PROTEIN-C RESISTANCE) [J].
ROSENDAAL, FR ;
KOSTER, T ;
VANDENBROUCKE, JP ;
REITSMA, PH .
BLOOD, 1995, 85 (06) :1504-1508
[66]   THROMBOEMBOLIC DISEASE IN PREGNANCY [J].
RUTHERFORD, SE ;
PHELAN, JP .
CLINICS IN PERINATOLOGY, 1986, 13 (04) :719-739
[67]  
Sanson BJ, 1996, THROMB HAEMOSTASIS, V75, P387
[68]  
SIPES SL, 1990, SEMIN PERINATOL, V14, P103
[69]  
*SMFM PRACT COMM, 2004, EN SOD LOV PREGN
[70]  
TAIT RC, 1995, THROMB HAEMOSTASIS, V73, P87